Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000133

Type of data
NGS (Target Capture): AML cancer panel
NGS (Target Capture): 41 genes
Access criteria
Controlled-access (Type I)
Total data volume
454 GB
File formats
  • FASTQ
Research
hum0116
Date published
2020-11-24
Date modified
2021-03-09
DDBJ Search
JGAD000133 (opens in a new tab)
JGA Study
JGAS000122 (opens in a new tab)

Analysis method

Targeted DNA sequencing

Materials and participants
AML (ICD10: C920): 19 cases
Leukemia stem cell: 33 samples, Pre-leukemia stem cell: 2 samples, T-cell: 6 samples, B-cell: 2 samples (total 43 samples)
37 human leukemia stem cell samples from 37 humanized mice with leukemia derived from immune deficiency mice which were infused with human leukemia stem cell from 12 patients with AML
  • Health status
    Affected
  • Subject count
    19 (Individual)
Disease
AML (C920)
Sample description
DNAs extracted from leukemia stem cells, pre-leukemia stem cells, T-cell and B-cells
DNAs extracted from leukemia stem cells from humanized mice with leukemia derived from immune deficiency mice which were infused with human leukemia stem cells
  • Tissue
    B cell, Leukemia stem cell, Pre-leukemic stem cell, T cell
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
xGen® Acute Myeloid Leukemia Cancer Panel
Reagent kit
KAPA Hyper Prep Kit
xGen Acute Myeloid Leukemia Cancer Panel
Fragmentation
N/A
Platform
Illumina HiSeq 1500
Read type
Single-end
Read length
50 bp
Data use policy
NBDC data sharing policy (JGAP000001)